FDA Advisory Panel Recommends More Regulation Of DTC Genetic Tests
An FDA advisory panel March 8 and 9 pressed CDRH to bring more physician oversight and regulation into direct-to-consumer genetic testing.
An FDA advisory panel March 8 and 9 pressed CDRH to bring more physician oversight and regulation into direct-to-consumer genetic testing.